Clinical utility of RAS mutations in thyroid cancer: a blurred picture now emerging clearer.
about
A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinomaInvasive follicular variant of papillary thyroid cancer harboring the NRAS mutation Q61K and presenting with bone metastasis-A case report.Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model.BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment.TERT promoter mutations and their correlation with BRAF and RAS mutations in a consecutive cohort of 145 thyroid cancer cases.Prognosis of FTC compared to PTC and FVPTC: findings based on SEER database using propensity score matching analysis
P2860
Clinical utility of RAS mutations in thyroid cancer: a blurred picture now emerging clearer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Clinical utility of RAS mutati ...... picture now emerging clearer.
@ast
Clinical utility of RAS mutati ...... picture now emerging clearer.
@en
type
label
Clinical utility of RAS mutati ...... picture now emerging clearer.
@ast
Clinical utility of RAS mutati ...... picture now emerging clearer.
@en
prefLabel
Clinical utility of RAS mutati ...... picture now emerging clearer.
@ast
Clinical utility of RAS mutati ...... picture now emerging clearer.
@en
P2860
P1433
P1476
Clinical utility of RAS mutati ...... picture now emerging clearer.
@en
P2093
Mingzhao Xing
P2860
P2888
P356
10.1186/S12916-016-0559-9
P407
P577
2016-01-27T00:00:00Z
P5875
P6179
1009401475